8-K 1 med011204-8k.txt MEDAMICUS, INC. FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED) : APRIL 26, 2001 COMMISSION FILE NUMBER 0-19467 MEDAMICUS, INC. (Exact name of registrant as specified in its charter) MINNESOTA 41-1533300 (State of Incorporation) (IRS Employer Identification No.) 15301 HIGHWAY 55 WEST, PLYMOUTH, MN 55447 (Address of principal executive office, including zip code) (763) 559-2613 (Registrant's telephone number, including area code) N/A -------------------------------------------------------------------------------- Former name, former address and former fiscal year, if changed since last report ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS Exhibit 99.1 Power Point presentation delivered by Registrant's President, Chief Executive Officer and Chief Financial Officer at the annual meeting of the Registrant's shareholders held April 26, 2001. ITEM 9. REGULATION FD DISCLOSURE. MedAmicus, Inc.'s ("MedAmicus") President, Chief Executive Officer and Chief Financial Officer, James D. Hartman, delivered a presentation at the annual meeting of MedAmicus' shareholders held April 26, 2001. A text version of the Power Point presentation is attached as Exhibit 99.1. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized: MEDAMICUS, INC. Date: April 27, 2001 /s/ James D. Hartman -------------------- By: James D. Hartman President, Chief Executive Officer and Chief Financial Officer 2